FDA panel backs Amgen cholesterol drug for some patients

Wednesday, June 10, 2015 - 15:30 in Health & Medicine

WASHINGTON (AP) -- Federal health advisers say a highly-anticipated cholesterol-lowering drug from Amgen Inc. should be approved for some patients with dangerously high levels of the artery-clogging substance....

Read the whole article on AP Health

More from AP Health

Latest Science Newsletter

Get the latest and most popular science news articles of the week in your Inbox! It's free!

Check out our next project, Biology.Net